Vishwas H Devaiah, associate professor at Jindal Global Law School and executive director of the Centre for Intellectual Property Rights Studies, talks to Managing IP about the continuing evolution of ...

India’s Controller of Patents has issued a compulsory licence over a cancer-treating drug, sorafenib, whose patent is held by Bayer The decision, published today, means that Indian generic drug maker ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The Health Ministry in India has recommended that a compulsory licence (CL) is issued for the manufacture of Bristol-Myers Squibb’s (BMS) anti-cancer drug Sprycel (dasatinib), potentially opening the ...